Lipum AB engages in the research and development of novel anti-inflammatory drugs. It focuses in chronic inflammatory diseases. The company was founded by Olle Carl Hernell, Lennart Gustav Lundberg, and Susanne Eva Lindquist on June 17, 2010 and is headquartered in Umea, Sweden.